Anticancer agent 235

SKU: orb2646364

Description

Anticanceragent 235 (Compound 49) is a small molecule PI3K/AKT/mTOR pathway modulator that induces oxidative stress and mitochondrial dysfunction, leading to cell cycle arrest and apoptosis. It demonstrates potent in vitro anti-proliferative activity against various cancer cell lines, including HCT116 and Caco-2, supporting its use in oncology and signal transduction research.

Research Area

Cell Biology, Immunology & Inflammation, Metabolism Research, Signal Transduction

Images & Validation

−

Key Properties

−

CAS Number	2411108-21-7
MW	296.75
Formula	C₁₇H₁₃ClN₂O
SMILES	ClC1=CC=C2C(=C1)C=C3C(=NC=4C=C(OC)C=CC43)N2C
Target	Reactive Oxygen Species,Apoptosis,Akt,PI3K

Storage & Handling

−

Storage	-20°C
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Compound Identifiers

PubChem CID

172419318 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols